ARCHIVES

FDA Proposes Office For Patients With Life Threatening Disease

This article is from The Cancer Letter archive.

Vol. 18 No. 44 | November 13, 1992

Download PDF Visit The Full Archive

Related Articles

Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin

January 16, 2009

Cancer Control Emphasis Shift to Prevention Projected For Y 1978; Advisors Seek More

July 29, 1977

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

July 30, 1999

Metastasis Research Is Example Of Progress Under 1971 Cancer Act

May 10, 1991

ACS Division Help Fund Some CIS Offices

September 13, 1985

Lapatinib Improves Outcome Of Advanced Breast Cancer

July 28, 2006